Oaktree Capital Management »

Cytokinetics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $7.1M 6.7M 1.07
2025-03-31 $7.3M 6.4M 1.15
2024-12-31 $8.3M 7.0M 1.19
2024-09-30 $2.2M 1.7M 1.29

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Expand Energy Corp Common Stock (EXE)
Garrett Motion Common Stock (GTX)
Anglogold Ashanti Common Stock (AU)
Viper Energy Common Stock (VNOM)
State Street Corp Etf Put Option (SPY)
Talen Energy Corp Common Stock Call Option (TLN)
Telephone And Data Systems Common Stock (TDS)
Oracle Corp Common Stock Put Option (ORCL)
Sunopta Common Stock (STKL)
Core Scientific Common Stock (CORZ)
Barrick Mining Corp Common Stock (B)
Liberty Global Common Stock (LBTYA)
Ftai Aviation Common Stock (FTAI)
Cemex Sab De Cv Common Stock (CX)

View all positions for Oaktree Capital Management

Top funds holding Cytokinetics

FMR
Balyasny Asset Management
Wellington Management Company
Lazard Asset Management
Goldman Sachs Group
Capstone Investment Advisors
Leucadia National Corporation
Wells Fargo & Company
AXA Investment Managers
Bnp Paribas Investment Partners
Gabelli Funds
Jpmorgan Chase & Co
Jane Street
Shenkman Capital Management
Bank of New York Mellon

View all funds holding Cytokinetics